Wikisage, the free encyclopedia of the second generation, is digital heritage
Neurocysticercosis: Difference between revisions
Jump to navigation
Jump to search
m (title) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
Neurocysticercosis is a contributor of late onset [[epilepsy]]<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340353/pdf/pntd.0005153.pdf Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy]</ref> | Neurocysticercosis is a contributor of late onset [[epilepsy]]<ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340353/pdf/pntd.0005153.pdf Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy]</ref> | ||
{{disease|B 69.0|neurocysticercosis}} | {{disease|B 69.0|neurocysticercosis}} | ||
Revision as of 00:17, 26 August 2017
Neurocysticercosis is a contributor of late onset epilepsy[1]
Disease classification WHO
B 69.0 neurocysticercosis
Several studies have reported an association between epilepsy and NC based on positive serum antibodies against Taenia solium, which has distorted the perception of the epidemiology of epilepsy related to NC. Immunoserologic assays, such as enzyme-linked immunoelectrotransfer blot assay (EITB) or enzyme-linked immunosorbent assay (ELISA), detect antibodies against T. solium
